BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 33974808)

  • 1. Saikosaponin-d protects against liver fibrosis by regulating the estrogen receptor-β/NLRP3 inflammasome pathway.
    Lin L; Zhou M; Que R; Chen Y; Liu X; Zhang K; Shi Z; Li Y
    Biochem Cell Biol; 2021 Oct; 99(5):666-674. PubMed ID: 33974808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Saikosaponin-d alleviates hepatic fibrosis through regulating GPER1/autophagy signaling.
    Chen Y; Que R; Zhang N; Lin L; Zhou M; Li Y
    Mol Biol Rep; 2021 Dec; 48(12):7853-7863. PubMed ID: 34714484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of oxidative stress and NLRP3 inflammasome by Saikosaponin-d alleviates acute liver injury in carbon tetrachloride-induced hepatitis in mice.
    Chen Y; Que R; Lin L; Shen Y; Liu J; Li Y
    Int J Immunopathol Pharmacol; 2020; 34():2058738420950593. PubMed ID: 32816567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Saikosaponin d Alleviates Liver Fibrosis by Negatively Regulating the ROS/NLRP3 Inflammasome Through Activating the ERβ Pathway.
    Zhang K; Lin L; Zhu Y; Zhang N; Zhou M; Li Y
    Front Pharmacol; 2022; 13():894981. PubMed ID: 35694250
    [No Abstract]   [Full Text] [Related]  

  • 5. NLR Family Pyrin Domain-Containing 3 Inflammasome Activation in Hepatic Stellate Cells Induces Liver Fibrosis in Mice.
    Inzaugarat ME; Johnson CD; Holtmann TM; McGeough MD; Trautwein C; Papouchado BG; Schwabe R; Hoffman HM; Wree A; Feldstein AE
    Hepatology; 2019 Feb; 69(2):845-859. PubMed ID: 30180270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estrogen receptor‑β‑dependent effects of saikosaponin‑d on the suppression of oxidative stress‑induced rat hepatic stellate cell activation.
    Que R; Shen Y; Ren J; Tao Z; Zhu X; Li Y
    Int J Mol Med; 2018 Mar; 41(3):1357-1364. PubMed ID: 29286085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitochondria-targeted reactive oxygen species blockor SS-31 blocks hepatic stellate cell activation and alleviates hepatic fibrosis by regulating NLRP3 inflammasomes.
    Liu L; Wei Y; Xie N; Cai H; Lin Y
    Cell Mol Biol (Noisy-le-grand); 2024 Feb; 70(2):183-188. PubMed ID: 38430023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Saikosaponin‑d alleviates carbon‑tetrachloride induced acute hepatocellular injury by inhibiting oxidative stress and NLRP3 inflammasome activation in the HL‑7702 cell line.
    Lin L; Que R; Shen Y; Chen Y; Yan N; Li Y
    Mol Med Rep; 2018 Jun; 17(6):7939-7946. PubMed ID: 29620210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Auranofin prevents liver fibrosis by system Xc-mediated inhibition of NLRP3 inflammasome.
    Kim HY; Choi YJ; Kim SK; Kim H; Jun DW; Yoon K; Kim N; Hwang J; Kim YM; Lim SC; Kang KW
    Commun Biol; 2021 Jun; 4(1):824. PubMed ID: 34193972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Saikosaponin A of Bupleurum chinense (Chaihu) elevates bone morphogenetic protein 4 (BMP-4) during hepatic stellate cell activation.
    Wang X; Wang Q; Burczynski FJ; Kong W; Gong Y
    Phytomedicine; 2013 Nov; 20(14):1330-5. PubMed ID: 23969230
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Saikosaponin-d alleviates depression by promoting NLRP3 ubiquitination and inhibiting inflammasome activation.
    Gao T; Wang T; Wu L; Tong Y; Tian J; Zhao K; Wang H
    Int Immunopharmacol; 2024 Jan; 127():111324. PubMed ID: 38070467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Saikosaponin A inhibits the activation of pancreatic stellate cells by suppressing autophagy and the NLRP3 inflammasome via the AMPK/mTOR pathway.
    Cui L; Li C; Zhuo Y; Yang L; Cui N; Li Y; Zhang S
    Biomed Pharmacother; 2020 Aug; 128():110216. PubMed ID: 32497863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiotensin-(1-7) Improves Liver Fibrosis by Regulating the NLRP3 Inflammasome via Redox Balance Modulation.
    Cai SM; Yang RQ; Li Y; Ning ZW; Zhang LL; Zhou GS; Luo W; Li DH; Chen Y; Pan MX; Li X
    Antioxid Redox Signal; 2016 May; 24(14):795-812. PubMed ID: 26728324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dehydromevalonolactone ameliorates liver fibrosis and inflammation by repressing activation of NLRP3 inflammasome.
    Niu WX; Bao YY; Zhang N; Lu ZN; Ge MX; Li YM; Li Y; Chen MH; He HW
    Bioorg Chem; 2022 Oct; 127():105971. PubMed ID: 35749855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oridonin ameliorates carbon tetrachloride-induced liver fibrosis in mice through inhibition of the NLRP3 inflammasome.
    Liu D; Qin H; Yang B; Du B; Yun X
    Drug Dev Res; 2020 Jun; 81(4):526-533. PubMed ID: 32219880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alpinetin exerts anti-inflammatory, anti-oxidative and anti-angiogenic effects through activating the Nrf2 pathway and inhibiting NLRP3 pathway in carbon tetrachloride-induced liver fibrosis.
    Zhu Z; Hu R; Li J; Xing X; Chen J; Zhou Q; Sun J
    Int Immunopharmacol; 2021 Jul; 96():107660. PubMed ID: 33862553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p66Shc Contributes to Liver Fibrosis through the Regulation of Mitochondrial Reactive Oxygen Species.
    Zhao Y; Wang Z; Feng D; Zhao H; Lin M; Hu Y; Zhang N; Lv L; Gao Z; Zhai X; Tian X; Yao J
    Theranostics; 2019; 9(5):1510-1522. PubMed ID: 30867846
    [No Abstract]   [Full Text] [Related]  

  • 18. Role of aldosterone in the activation of primary mice hepatic stellate cell and liver fibrosis via NLRP3 inflammasome.
    Li Y; Zhang Y; Chen T; Huang Y; Zhang Y; Geng S; Li X
    J Gastroenterol Hepatol; 2020 Jun; 35(6):1069-1077. PubMed ID: 31860730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pelargonidin ameliorates CCl
    Shi YS; Li XX; Li HT; Zhang Y
    Food Funct; 2020 Jun; 11(6):5156-5165. PubMed ID: 32432601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The anti-liver fibrosis effect of Tibetan medicine (Qiwei Tiexie capsule) is related to the inhibition of NLRP3 inflammasome activation in vivo and in vitro.
    Wang S; Ye F; Ren Q; Sun S; Xia W; Wang Z; Guo H; Li H; Zhang S; Lowe S; Chen M; Du Q; Weihong Li
    J Ethnopharmacol; 2024 Jan; 319(Pt 2):117283. PubMed ID: 37827298
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.